Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 225 publications
IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.
Journal: Future oncology (London, England)
Published: June 19, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.
Journal: Neuro-oncology advances
Published: October 24, 2025
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Journal: Neuro-oncology
Published: August 19, 2025
Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.
Journal: Neuro-oncology
Published: August 04, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastoma.
Journal: Neuro-oncology practice
Published: June 09, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.
Journal: Neuro-oncology
Published: April 12, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.
Journal: Neuro-oncology advances
Published: February 06, 2025
Last Updated: 09/26/2026